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Regulation of the  immune response by interactions between  idiotypes  (Id  a)  and 
anti-Id has been established in several different experimental systems (for review see 
1-4). In some, administration of exogenous anti-Id antibody has been used, whereas 
in others the production of auto-anti-Id during the course of an immune response has 
been identified (5-10). In general, the appearance of auto-anti-Id correlates with the 
down-regulation of the immune response. The mechanisms  involved in this down- 
regulation are unclear, although suppressor T  cells (Ts)  (10), inhibition of antibody 
secretion by anti-Id binding to B cell receptors (9), and elimination of Id  + cells by 
complement (C)-mediated lysis (11) have all been implicated. 
We have shown that the duration of the primary contact sensitivity (CS) response 
to  2,4-dinitrofluorobenzene  (DNFB)  is  down-regulated  by  auto-anti-Id  antibodies 
(12). These anti-Id antibodies, which are detected in suppressive immune serum (SIS) 
9-15 d  after DNFB sensitization, specifically block the transfer of CS to DNFB.  In 
addition  to  this  naturally  occurring  auto-anti-Id  serum,  we  have also  prepared  a 
syngeneic anti-Id serum  in  BALB/c mice by repeated immunization with purified 
DNFB-sensitized  lymph  node  (LN)  T  cells  (TDH-DNP)  from  BALB/c  mice.  The 
properties  and  specificity of this  anti-Id  serum,  termed  syngeneic  anti-TDH-DNP 
serum, are described elsewhere.  2 These studies have shown that the auto-anti-Id and 
the syngeneic anti-Id have essentially the same properties. During the characterization 
of the syngeneic antiserum, we noted that the transfer of CS to DNFB was inhibited 
by treating immune LN cells with the serum with or without  C. The same results 
occurred when TDH-DNP cells were treated with the auto-anti-Id serum. Reasoning 
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that anti-Id inhibition of transfer of immunity without C  might be relevant to in vivo 
regulation by anti-Id, I  have examined the phenomenon in some detail. The results 
show that  this inhibition is an active process resulting from anti-Id activation of a 
subset  of Ia  +  T  ceils  in  the  immune LN  cell  population.  The  final  suppression 
mediated by the anti-Id-activated T  cells is antigen nonspecific. 
Materials and Methods 
Mice.  Male CBA/J mice were purchased from The Jackson Laboratory, Bar Harbor, ME. 
Sensitization with DNFB or Oxazolone (Ox).  To serve  as donors of immune LN cells,  mice 
were sensitized with DNFB by two daily paintings with 25 #1 of 0.5% DNFB on the shaved 
abdomen and 5 #1 on the footpads and ears. Ox sensitivity was induced by two paintings of 50 
/~1 of 3% Ox on the shaved abdomen and 5 #1 on the footpads and ears.  In some experiments, 
donor mice were doubly sensitized with DNFB and Ox. This was done by painting the left side 
of the clipped abdomen, left forepaw, and ear with DNFB and the right side of the abdomen, 
right forepaw, and ear with Ox. 
Transfer of Contact Sensitivity,  3  d  after  the  last  skin painting, single-cell suspensions of 
draining LN cells were prepared, and 4 ×  107 to 5 ×  107 cells were injected intravenously into 
normal syngeneic  recipients. All recipient groups contained at least four animals. The recipients 
and negative controls were challenged within 1 h after cell transfer by applying 20 #1 of 0.2% 
DNFB or 20 #1 of 1% Ox on the dorsal side of each ear. Increased ear swelling was measured 24 
h later with an engineer's micrometer and expressed  in units of 10  -4 in. 
Antiserum.  Anti-Ia  k serum was prepared by repeated injections of A.TH mice with spleen 
and LN cells from A.TL donors. Polyvalent rabbit anti-mouse immunoglobulin  serum (anti- 
MIg) was prepared as previously described (13). Before use, the antisera were heat inactivated 
at 56°C. Anti-MIg was also adsorbed with normal mouse thymocytes and erythrocytes (h 10 
vol/vol). The eytotoxieity and specificity of both antisera have been described (13, 14). 
Syngeneic anti°TDH-DNP serum (anti-Id) was prepared by repeatedly immunizing  BALB/c 
mice with purified LN T cells from DNFB-sensitized BALB/c mice.  2 SIS, which contains auto- 
anti-Id antibodies (12), was obtained by bleeding optimally DNFB-sensitized BALB/c mice 9, 
12, and 15 d after sensitization, and pooling the serum. 
For treatment of immune LN cells,  10  s cells/ml were suspended in h 10 diluted anti-Ia  k or 
anti-MIg, 1:2 diluted SIS, or 1:20 diluted syngeneic anti-TDH-DNP serum, and incubated for 
1 h  on ice. After washing, anti-Ia-, SIS-, and anti-TDH-DNP serum-treated cells were resus- 
pended in 1:20 rabbit C  (unless otherwise indicated), and anti-MIg-treated cells were resus- 
pended in 1:6 guinea pig C. The cells were then incubated for t0 min on ice followed by 30 
min at 37°C. 
Purification of T Cells.  LN T cells were purified on nylon wool columns using a modification 
(15)  of the  procedure  described  by Julius  et  al.  (16). Contamination of the  nylon wool 
nonadherent population with B cells, as judged by immunofluorescent  staining  with fluorescein- 
labeled rabbit anti-MIg (Meloy Laboratories Inc., Springfield, VA), was --<1%. 
Preparation and  Use of Immunoadsorbent Columns.  Affinity-purified normal MIg or  BALB/c 
anti-DNP antibodies (MaDNP)  were  conjugated to  Sepharose  4B  beads  (Pharmacia Fine 
Chemicals, Div. of Pharmacia Inc., Piscataway, N  J) according to the standard labeling  protocol. 
20-ml plastic syringes filtered with  plastic discs  (Bel-Art  Products,  Pequannock, NJ)  were 
packed with 5-7 ml of the appropriate Sepharose conjugate. Before  use,  the columns were 
washed with 60 ml phosphate-buffered saline (PBS,  pH 7.3) and 30 ml 0.1  M  NH4OH, and 
then equilibrated with PBS. 2.5 ml of 1:20 syngeneic anti-TDn-DNP serum was then added to 
the column and washed through slowly with 25 ml of PBS. 25 ml of effluent was collected and 
concentrated  to  2  ml  using an  Amicon Uhrafihration cell  fitted  with  an  XM50  Diaflo 
Ultramembrane (Ainicon Corp., Scientific Sys. Div., Lexington, MA). Column-bound  material 
was eluted with 25 ml of 0.1  M  NH4OH. The eluate was neutralized immediately with 1 N 
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Results 
Inhibition by Anti- TDx-DNP Serum of Transfer of Immunity: Lack of Requirement for C.  As 
shown previously,  2 treatment of DNFB-immune LN cells with syngeneic anti-TDH- 
DNP serum plus C  inhibits  the ability of the treated cells to transfer immunity to 
DNFB. We found, however, that C was not absolutely required for the inhibition of 
transfer of CS. Retesting of anti-Id-containing SIS gave similar results; SIS treatment 
of DNFB-immune  LN cells inhibited  transfer of sensitivity, whether or not C  was 
added. Representative results of this basic phenomenon for the two sera are given in 
Table I. Experiment 1 shows results obtained using unseparated DNFB-sensitized LN 
cells, whereas results given for experiment 2 were obtained using nylon wool-purified 
DNFB-sensitized  LN T  Cells.  As  shown,  similar  levels of inhibition  of transfer of 
immunity  occurred whether or  not  the  antiserum-treated  cells  were  subsequently 
treated with C. 
All experiments reported here have been done comparing SIS with anti-TDH-DNP 
serum, and similar results have been obtained. For ease of presentation, however, only 
those results obtained using syngeneic anti-TDH-DNP serum will be shown. 
Inhibition of Transfer of Immunity by Treating LN Cells with Anti- TDH-DNP Serum without 
C Requires Ia + T GeUs in the Immune LN Population.  At least three explanations would 
account for the inhibition of transfer of immunity by antiserum treatment without C. 
These are (a) anti-Id antibodies blocking the antigen receptor on TDH-DNP effector 
T  cells; (b) there is C-mediated lysis of the effector T  cells after transfer to the normal 
recipients; and (c) anti-Id activates some T  cell subset resulting in suppression of the 
effeetor TDH-DNP cells. This latter possibility was considered because we have shown 
that LN cells from DNFB-sensitized mice are heterogeneous, containing at least three 
subsets of T  cells, i.e., Ia- TDH-DNP effector T  cells (14), Ia  + T  cells (Tprlf), which 
proliferate upon antigen restimulation in vitro (14), and Ia  + auxiliary suppressor T 
cells  (Ts-aux), which together with Ts suppress effector functions of the TDH-DNP 
cells (17). To specifically look at the third possibility, LN cells from DNFB-sensitized 
mice were pretreated with NMS or anti-Ia serum plus C. The washed cells were then 
treated  with  syngeneic anti-TDH-DNP  serum  plus  or minus  C  and  transferred to 
TABLE I 
Complement-independent Inhibition of Transfer of Contact Sensitivity to DNFB by Treatment with 
Anti-TDH-DNP Serum or Suppressive Immune Serum 
Experiment 1"  Experiment 2:~ 
Serum treatment of  Experi-  Group  A Ear swelling  Percent  A Ear swelling  Percent 
ment  immune LN cells  (×  10  -4 in.  inhibi-  (×  10  -4 in.  inhibi- 
±  SEM)  tion  ±  SEM)  tion 
II 
A  NMS +  C  42.8 ±  3.1  26.5 ±  1.9 
B  Anti-TDH-DNP +  C  11.7 ±  1.9§  73  6.2 ±  2.1§  77 
C  Anti-TDH-DNP  15.9 ±  2.1§  63  10.6 ±  1.4§  60 
A  NMS +  C  33.4 ±  3.6  24.0 ±  2.2 
B  SIS +  C  14.6 +  0.8§  56  11.7 +  1.4§  51 
C  SIS  16.4 ±  2.2§  51  10.1 ±  2.9~  58 
* Unseparated LN cells used in experiment 1. 
Nylon wool-purified LN T  cells used in experiment 
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syngeneic recipients to assess their ability to transfer immunity. The results are given 
in Table II. Treatment of immune LN cells with NMS plus C  did not alter the ability 
of the syngeneic anti-TDvi-DNP serum (without C) to inhibit the transfer of immunity 
(compare group B with A). In contrast, pretreating the immune LN cells with anti-Ia 
plus C eliminated the inhibitory effect of the syngeneic antiserum (group C). However, 
if the syngeneic antiserum  was used with C  (group D), transfer of immunity by the 
immune  LN  cells  depleted  of  Ia  ÷  cells  was  inhibited.  Depletion  of  B  cells  by 
pretreatment  with  anti-MIg plus C  (group  E)  had  no effect on  the C-independent 
inhibition  of transfer.  These  results  indicate  that  the  C-independent  inhibition  of 
transfer of immunity by syngeneic anti-TDH-DNP serum requires the presence of Ia  + 
T  cells in the DNFB-sensitized LN population. 
Ia + T  Cells Needed for  C-independent Inhibition  by Syngeneic Anti-Ton-DNP Serum Are 
Found in  Sensitized  but Not Normal  LN Cells.  To  determine  if the  Ia  +  T  cells  were 
ubiquitous or required antigen activation, 2 ×  10  s DNFB-immune LN cells depleted 
of Ia  + cells were mixed with untreated  LN T  ceils from normal or DNFB-sensitized 
mice.  The  cell  mixtures  were  then  treated  with  syngeneic  anti-Tnn-DNP  serum 
without C  and  transferred  to normal  recipients  that  were then  ear challenged with 
DNFB. Results of such an experiment are given in Table III. As previously described, 
immune  LN cells  depleted  of Ia  + cells were no longer inhibited  by anti-Tol~-DNP 
serum  without  C  (group  C).  Addition  of  10  s  untreated  LN  T  cells  from  DNFB- 
sensitized mice restored the inhibition  (group D), whereas addition of 10  s normal LN 
T  cells  had  no effect  (group  E).  These  findings  indicate  that  antigen  activation  is 
necessary to induce Ia  + T  cells, which are required  for C-independent  inhibition  by 
syngeneic anti-TDrt-DNP serum of transfer of immunity. 
Complement-independent Inhibition  of Transfer of Immunity  Induced by Syngeneic Anti-Ton- 
DNP Serum is due to Anti-Id Antibodies.  When used with C, the inhibitory activity of 
syngeneic anti-Tim-DNP serum is due to anti-Id antibodies. 2 Thus, experiments were 
done to determine  if anti-Id antibodies were also responsible for the C-independent 
inhibition  of transfer  oLimmunity.  2.5  ml  of 1:20 syngeneic anti-Tim-DNP  serum 
were passed through Sepharose columns conjugated with either affinity-purified MIg 
or  mouse  anti-DNP  antibodies.  The  column  effluent  and  NH4OH  eluate  were 
TABL~ II 
Complement-independent Anti-Tox-DNP Serum Inhibition of Transfer of Contact Sensitivity: 
Requirement of Ia ÷ T Cells 
Serum treatment of DNFB-sensitized 
LN cells  Experiment 1  Experiment 2 
Group 
1st treatment  2nd treatment 
Per-  A Ear  A Ear  Per- 
swelling  cent  swelling  cent 
(× 10  -4 in.  inhi-  (× 10  -4 in.  inhi- 
bi- 
+ SEM)  tion  + SEM)  bition 
A  None  NMS + C 
B  NMS + C  Anti-TDn-DNP 
C  Anti-Ia + C  Anti-Ttm-DNP 
D  Anti-Ia + C  Anti-TDH-DNP  + C 
E  Anti-MIg + C  Anti-Trm-DNP 
69.0:1:5.7  42.8 :l: 4.0 
29.4 :t: 3.1"  57  15.0:1: 1.9" 
71.6 :::1:6.1  0  36.9 ::1:3.3 
23.9:1: 2.2*  65  16.3:1: 0.8* 
31.7 + 3.4*  54  15.9 +  1.9" 
65 
14 
62 
63 
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TABLE III 
Ia + T Cells Required  for Complement-independent Anti-Ton-DNP Serum Inhibition of Transfer of Contact 
Sensitivity Are Induced by Antigen 
Group 
1st treatment 
Treatment of DNFB-sensitized  LN cells  Per- 
A Ear swelling  cent 
Cells added after 1st  (X 10  -4 in.  inhi- 
treatment*  2nd treatment  ± SEM)  bition 
A  NMS + C  --  NMS  50.5 ± 4.8 
B  NMS + C  --  Anti-Ttm-DNP  t9.2 ± 2.5~:  62 
C  Anti-Ia + C  --  Anti-TDn-DNP  49.6 ± 3.0  2 
D  Anti-Ia + C  Untreated DNFB-  Anti-TDH-DNP  26.0 ± 3.1§  48 
sensitized LN T cells 
E  Anti-Is + C  Normal  LN T Cells  Anti-ToH-DNP  56.2 + 5.7  0 
* LN T cells purified on nylon wool. 
,P<  o.001. 
§P< 0,01. 
TASLE IV 
Anti-ld Antibodies m Anti- Ton-DNP Serum Mediate the Complement-independent Inhibition of Transfer 
of Contact Sensitivity 
Group 
Serum treatment of DNFB-sensitized  LN cells 
Serum  Treatment of serum 
A Ear swelling  Percent 
(X 10  -4 in.  inhibi- 
+ SEM)  tion 
A  NMS  --  33.8 + 2.9 
B  Anti-TDn-DNP  MIg column effluent  7.6 +  1.7"  78 
C  Anti-TDH-DNP  MIg column eluate  35.5 ± 4.1  0 
D  Anti-TDH-DNP  MaDNP column effluent  30.4 ± 3.8  l0 
E  Anti-TDH-DNP  MaDNP column eluate  3.0 + 0.6*  91 
*e<o.ool. 
collected and concentrated, and tested  without C  on  DNFB-immune LN  cells for 
inhibition of transfer of immunity. The results are given in Table IV. Passage of the 
antiserum through the MIg column had no effect as all of the inhibitory activity was 
found in the column effluent (group B). In contrast, when the antiserum was passed 
through the MaDNP column, virtually all of the inhibitory activity was found in the 
column eluate (group E), indicating that the anti-Id antibodies in the syngeneic anti- 
TDH-DNP  serum  are  responsible  for  the  C-independent inhibition of  transfer  of 
immunity. 
Suppression  by Anti-Id-activated Ia ÷ T Cells is Antigen Nonspecific.  In some experimental 
systems it has been shown that the final step of suppression in regulatory pathways is 
antigen nonspecific (18).  To examine this question in the contact system, LN cells 
from  mice doubly sensitized with  DNFB  and Ox  were  prepared  and treated with 
either NMS or syngeneic anti-TDH-DNP serum (10  s cells/ml of 1:20 serum) for 1 h on 
ice. After washing, the cells were resuspended at  10  s cells/ml and 0.5 ml injected i.v. 
into normal recipients.  DNFB  ear  challenges were  made on  half of the  recipients 
receiving NMS-treated cells, half receiving anti-TDn-DNP serum-treated cells, and 
four  negative control  mice.  The  remaining recipients and  negative controls were 
challenged with Ox and ear swelling was measured 24 h  later. As shown in Table V, 
the transfer of CS to DNFB by LN cells from the doubly-sensitized  mice was inhibited 
by treating the cells with syngeneic anti-TDrt-DNP serum  (group B).  However, the JOHN  W.  MOORHEAD  825 
TABLE V 
Passive Transfer of Systemic Immunity: Complement-independent Inhibition by Anti-Id Antibody 
Appears Antigen Specific 
LN cells  Serum treatment of LN  Ear challenge  A Ear swelling 
Group  transferred  cells from DNFB + Ox-  antigen  (X l0  -4 in.  Percent 
(X 107)  sensitized mice  ± SEM)  inhibition 
A  5.0  NMS  DNFB  28.9 :t: 2.1 
B  5.0  Anti-TDn-DNP  DNFB  5.2 :t: 0.7*  82 
C  5.0  NMS  Ox  36.9 + 4.1 
D  5.0  Anti-TDn-DNP  Ox  32.2 ± 3.6  13 
* P< 0,001. 
TABLE VI 
Final Supp~ssionlnduced ~  Anti-IdAntibodyis Ant~enNonspecificand Occu~ Local& 
Group 
Cells transferred 
Intraear  Intravenous 
Ear  chal-  A Ear swelling  Percent 
lenge  (X 10  -4 in.  inhibi- 
antigen  + SEM)  tion 
A  NMS-treated  DNFB-  Ox-immune LN  Ox  42.8 :t: 3.7 
immune LN 
B  Anti-TDH-DNP-treated  Ox-immune LN  Ox  6.7 + 2.3*  84 
DNFB-immune LN 
*  P<  0.001. 
ability of these same LN cells to transfer CS to Ox was unaffected by the antiserum 
treatment  (group  D).  These  results  indicate  that  the  inhibition  is  antigen  specific. 
However, we considered the possibility that  the suppressive signals delivered by the 
anti-Id-activated, Ia  + T  cells might  occur locally at  the skin test site. If so,  anti-Id- 
treated  DNP-specific  T  cells  injected  intravenously  into  mice  challenged  with  Ox 
would not arrive at the skin test site to any significant degree. This could account for 
the results given in Table V. To explore this possibility, the following experiment was 
done.  LN cells from  DNFB-sensitized mice were treated in vitro with NMS  or anti- 
TDH-DNP  serum.  After washing,  the cells were  resuspended  at  3  ×  10  s  to  4  ×  l0  s 
cells/ml in RPMI  medium and  10 #l (3-4 ×  106 cells) injected intradermally into the 
dorsal side of the ears of normal  mice.  LN cells from  Ox-sensitized mice were  then 
prepared and 5  ×  107 cells were injected intravenously into the mice previously given 
the  intraear  (IE)  injection.  Negative  control  mice  received  normal  mouse  serum 
(NMS)-treated  DNFB-immune  cells  IE,  but  did  not  receive Ox-immune  cells.  All 
mice were ear challenged with Ox, and ear swelling was measured 24 h  later. Results 
of such  an  experiment  are given in  Table VI.  As shown,  IE  injection of anti-TDH- 
DNP  serum-treated  LN cells from  DNFB-sensitized mice suppressed the transfer of 
immunity  by  intravenous  injected  Ox-immune  LN  cells  by  84%.  This  antigen- 
nonspecific  suppression  is  dependent  on  Ia  +  cells  in  the  DNFB-immune  LN  cell 
population as shown in Table VII. Here, the same protocol was used, except that the 
DNFB-sensitized LN cells were pretreated with anti-Ia serum plus C  before treatment 
with  the  syngeneic anti-TDH-DNP  serum.  Pretreatment  with  anti-Ia serum  plus  C 
reversed suppression of the Ox response from 83%  (group B) to 28%  (group C), which 
was not significantly different from the control response (group A). 826  NEGATIVE FEEDBACK  REGULATION  BY  AUTO-ANTI-IDIOTYPE 
TABLE  VII 
Local Antigen-Nonspecific Suppression Requires la + T Cells 
Group 
Cells transferred  Ear 
Pretreatment  thai-  A Ear swell-  Per- 
ing  cent 
of DNFB  lenge  (×  10 -4 in.  inhibi- 
immune  Intraear  Intravenous  anti- 
LN cells  +  SEM)  tion 
gen 
A  NMS +  C  NMS-treated DNFB-  Ox-immune LN  Ox  38.1 ~  4.3 
immune LN 
B  NMS +  C  Anti-Tim-DNP-treated  Ox-immune LN  Ox  6.5 :t:  1.6"  83 
DNFB-immune LN 
C  Anti-Ia +  C  Anti-Ttm-DNP-treated  Ox-immune LN  Ox  27.3 +  3.8  28 
DNFB-immune LN 
* P <  0.001. 
Discussion 
Considerable  experimental evidence  now  exists  supporting Jerne's  proposal  (19) 
that  the  magnitude  and  duration  of an  immune response is  regulated,  in  part,  by 
interactions between Id and anti-Id antibodies or membrane receptors. Of particular 
interest are those experimental systems which have shown, after immunization with 
antigen,  the  production  of auto-anti-Id  antibodies  (5-12).  These  systems  provide 
direct  proof for the potent regulatory effects of anti-Id antibodies  that occur under 
natural  conditions.  We have shown  that  CS  to DNFB  is regulated  by auto-anti-Id 
antibody.  Specifically, effector functions of the DNFB-sensitized T  cells  (TDH-DNP) 
are inhibited by auto-anti-Id, which appears in the serum of mice 9-15 d after DNFB 
sensitization  (t2). The experiments described in this report were done to investigate 
the  mechanism(s)  involved  in  this  regulation.  Using  transfer  of CS  to  mimic  the 
natural  effector phase of the  reaction  and  either  auto-anti-Id or syngeneic anti-Id 
antibodies,  the results indicate  that  in  vivo regulation  by anti-Id is a  complement- 
independent,  active process which involves anti-Id activation of a  subset of Ia  +, Id  + 
T  cells. These T  cells are present in the immune LN cell population but not in normal 
populations indicating that they are induced by antigen.  Once activated by anti-Id, 
these T cells suppress effector mechanisms of the CS reaction in an antigen-nonspeeific 
way. 
Previous studies from our laboratory have shown the presence of functional Ia  + T 
cells in LN populations from mice optimally sensitized with DNFB. Some of these T 
cells  (Tprlf) proliferate in vitro upon restimulation with antigen  (14).  Of particular 
interest  here,  however,  is  another  functional  subset  we have termed  auxiliary sup- 
pressor T  cells  (Ts-aux).  Ts-aux is a  regulatory population.  The cells are  I-J  +  and 
precursors are sensitive to cyclophosphamide and  are relatively short  lived  (18).  In 
order  for TDH-DNP effeetor cells to be regulated  by efferent acting Ts, there  is  an 
absolute requirement for Ts-aux in the immune population. In other words, the target 
for the exogenous Ts is Ts-aux, rather than the effector TDH population. We believe 
that Ts-aux and the Id  +, Ia  + T  cells we have identified here belong to the same T  cell 
subset. Further characterization is necessary, however, to show identity. 
Numerous studies have shown the requirement for T-T interactions in both positive 
and negative regulation of immune responses. Thus, it was not surprising to find that 
an  interaction  between  T  cells,  Ts-aux,  and  efferent  acting  Ts,  was  required  for JOHN  W,  MOORHEAD  827 
suppression of effector TDn cells.  What was surprising, however, was that one subset 
was present  in  the immune population and  apparently remained  immunologically 
silent unless Ts, raised in other animals, were added. Because efferent acting Ts (or 
other functional Ts, for that matter) are not detected in optimally sensitized mice, the 
role of Ts-aux cells in natural regulation of contact sensitivity remained obscure. The 
results  presented in  this report, we  believe, clarify this  issue.  It  appears  that  after 
antigen (DNFB) stimulation, Id  + clones of TDH and Ts-aux cells are expanded (Fig. 
1). The CS response mediated by TDn cells peaks 6  d  after sensitization. By day 9 
after sensitization, the CS response is no longer detectable, and this down-regulation 
is caused by auto-anti-Id antibodies (12). These antibodies are produced, I believe, in 
response to the  expanded numbers  of Id  + TDH and/or Ts-aux cells.  Regulation  is 
affected by the anti-Id antibodies binding to Id receptors on the Ts-aux population. 
This apparently activates the cells, which then suppress the effector TDn cells (Fig. 1). 
As shown by the data in Tables V and VI, this suppression is not systemic, but rather 
occurs locally at the skin test site and is antigen nonspecific. For reasons that are not 
clear, the anti-Id antibodies do not  sterically block the receptors on the TDn cells, 
although this binding occurs as evidenced by adsorption (12) and by C-mediated lysis 
of the cells in vitro. This indicates that lysis in vivo probably does not occur to any 
significant degree. Furthermore, it may be that steric inhibition of TDH does not occur 
in vivo, because once the anti-Id antibodies bind and cross-link the Id receptors, rapid 
shedding occurs with subsequent receptor re-expression. 
An important question, which cannot be answered by the present results, is whether 
cross-linking of Id  receptors on Ts-aux by anti-Id antibodies  is  the sole activating 
signal,  or whether other signals are also required.  Clearly, the results in Table VI, 
where anti-Id-treated DNFB-sensitized LN cells were injected directly into the ears of 
mice, which then received Ox-immune LN cells intravenously and Ox ear challenge, 
indicate that  exogenous DNFB as challenge antigen is not required to activate the 
cells. However, this does not preclude the possibility that interactions between Ts-aux 
and antigen-bearing or other cells contained in the locally transferred DNFB-sensitized 
population, might occur and be necessary for induction of the suppressive effect. It is 
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likely that suppression is mediated by a soluble factor produced by Ts-aux, although 
we have no data in this regard.  Experiments are currently underway to investigate 
these and other parameters of the system. 
Recent data indicate that Ts-aux-like cells are present in other experimental systems 
and function to regulate immune responses. For example, in delayed hypersensitivity 
(DH) to p-azobenzenearsonate (ABA), Sy et al.  (20)  have recently identified a  cross- 
reactive  idiotype  positive  (CRI  +)  T  cell  subset  in  ABA-sensitized  LN cells  that  is 
required for anti-CRI, efferent-acting Ts to suppress the transfer of DH. Suppression 
occurred  regardless  of whether  the  TDn-ABA  effector  cells  were  CRI  +  or  CRI-. 
Thomas et al. (21)  have also identified a subset of T  cells in ABA-sensitized lympho- 
cytes that  nonspecifically suppress transfer of DH following interaction  with ABA- 
coupled spleen cells in vitro. This subset was shown to be CRI  +. Also, a recent report 
by Sugimura,  et al.  (22)  suggests the presence of Ts-aux cells in  phosphorylcholine 
(PC)-sensitized  LN cells.  They found  that  treatment  of PC-sensitized  T  cells with 
anti-TI5  Id  serum  without  complement  blocked  the  transfer  of PC-specific  DH. 
Further  characterization  of other  experimental  systems  is  likely  to  reveal  similar 
phenomena. 
In conclusion, we have presented evidence indicating that natural regulation of CS 
to  DNFB  by auto-anti-Id  antibodies  involves a  negative  feedback regulatory loop. 
These data provide additional support for Jerne's network hypothesis (19) and further 
our understanding of the mechanisms involved in anti-Id regulation ofT cell reactions. 
Summary 
Contact sensitivity (CS)  to 2,4-dinitrofluorobenzene  (DNFB)  is maximal 6 d  after 
sensitization but declines rapidly. Previous studies have shown that this rapid decline 
is due to auto-anti-idiotypic  (anti-Id)  antibodies produced by the host. The present 
study was done to investigate the mechanism(s)  involved in this down-regulation of 
the  effector phase  of the  CS  reaction.  Using  transfer of CS  to  mimic  the  natural 
effector phase, we found that the inhibition of transfer by treating DNFB-sensitized 
lymph node (LN) cells with either auto-anti-Id or syngeneic anti-Id serum is comple- 
ment (C) independent. This inhibition requires Ia  + T  cells in the immune population. 
Depleting immune LN cells of Ia  + T  cells rendered them insensitive to inhibition by 
anti-Id alone, although the same population is inhibited by anti-Id plus C. This cell 
population is rendered sensitive to inhibition by anti-Id alone by addition of untreated 
DNFB-sensitized LN cells, but not by addition  of normal LN cells.  Further studies 
showed  that  the  suppression  of immunity  by  anti-Id-activated  Ia  +  T  cells  is  not 
systemic, but rather occurs locally at the skin test site and is antigen nonspecific. We 
interpret these data to indicate that the natural regulation of CS to DNFB by auto- 
anti-Id antibodies  is an active process that  involves a  negative feedback regulatory 
loop. 
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